Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Vehicles with electric motor
Methods and apparatuses for configuring and operating graphics processing units
Distributed IPv6 neighbor discovery for large datacenter switching systems
Method and apparatus for communications
Method of transmitting and receiving wireless resource information
Method and system for determining an optimal missile intercept approach direction for correct remote sensor-to-seeker handover
Management of memory array with magnetic random access memory (MRAM)
  Randomly Featured Patents
Snowmobile ski
Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
Flexible sealing unit for movable windows
Photoflash lamp unit
Wireless apparatus capable of controlling radiation patterns of antenna
Heater chips with silicon die bonded on silicon substrate, including offset wire bonding
Magneto-optoelectronic switch and sensor
Converter and power conversion device
Exposure method utilizing an energy beam
Multi-color print head for an ink-jet printer